Insulin Adjustments for Patients with Uncontrolled Glucose Levels
Insulin adjustments for patients with uncontrolled glucose should follow a systematic approach based on blood glucose patterns, with basal insulin starting at 10 units or 0.1-0.2 units/kg and titration based on self-monitoring of blood glucose (SMBG) levels. 1
Initial Insulin Therapy Approach
Starting Basal Insulin
- Begin with basal insulin at 10 units or 0.1-0.2 units/kg/day, depending on the degree of hyperglycemia 1
- Typically prescribed with metformin and possibly one additional non-insulin agent 1
- Set fasting plasma glucose (FPG) goals and choose an evidence-based titration algorithm 1
- Increase by approximately 2 units every 3 days to reach FPG goal without hypoglycemia 1
- If hypoglycemia occurs, determine the cause; if no clear reason is found, reduce dose by 10-20% 1
When to Consider Insulin Initiation
- Consider starting insulin when A1C ≥9% 1
- Start immediately when blood glucose ≥300-350 mg/dL (16.7-19.4 mmol/L) or A1C ≥10-12%, especially if symptomatic 1
- In cases of severe hyperglycemia with ketosis or unintentional weight loss, basal insulin plus mealtime insulin is the preferred initial regimen 1
Adjusting Insulin Therapy When Goals Are Not Met
When Basal Insulin Is Insufficient
- If basal insulin has been titrated to acceptable fasting blood glucose but A1C remains above target, advance to combination injectable therapy 1
- Options include:
Adding Prandial Insulin
- Start with one dose with the largest meal or meal with greatest postprandial glucose excursion 1
- Initial dose: 4 units per day or 10% of basal insulin dose 1
- Increase dose by 1-2 units or 10-15% based on postprandial glucose readings 1
- If A1C <8%, consider lowering the basal dose by 4 units or 10% when adding prandial insulin 1
- For hypoglycemia, determine cause; if no clear reason, lower corresponding dose by 10-20% 1
Full Basal-Bolus Regimen
- When stepping up to multiple daily injections, consider the following distribution 1:
Monitoring and Adjusting Insulin Therapy
Self-Monitoring of Blood Glucose (SMBG)
- Equipping patients with an algorithm for self-titration based on SMBG improves glycemic control 1
- Adjustments to both basal and prandial insulins should be based on prevailing blood glucose levels 1
- Pattern control requires understanding the pharmacodynamic profile of each insulin formulation 1
Continuous Glucose Monitoring (CGM)
- CGM provides real-time insights into glucose dynamics and trends, which can guide more precise insulin adjustments 2
- When using CGM data, patients often make larger insulin adjustments than commonly recommended:
Special Considerations
Hypoglycemia Management
- If hypoglycemia occurs, determine the cause and reduce the insulin dose by 10-20% if no clear reason is identified 1
- Patients should carry at least 15g of carbohydrate to treat hypoglycemic episodes 1
- Family members should be instructed in glucagon use for severe hypoglycemia 1
Insulin Administration Sites
- Rotation of injection sites is important to prevent lipohypertrophy or lipoatrophy 1
- Systematic rotation within one area (e.g., abdomen) is recommended rather than rotating between different areas 1
- Absorption rates differ by site: abdomen (fastest) > arms > thighs > buttocks 1
- Exercise increases absorption rates from injection sites 1
During Illness
- Continue insulin even when the patient is unable to eat or is vomiting 1
- More frequent SMBG may be required during illness, travel, or changes in routine 1
Adjustments in Hospital Settings
For Critically Ill Patients
- Use intravenous insulin infusion with a starting threshold of no higher than 180 mg/dL 1
- Maintain glucose levels between 140-180 mg/dL (7.8-10.0 mmol/L) 1
- Lower targets (120-140 mg/dL) may be appropriate in select patients 1
For Non-Critically Ill Patients
- Target premeal glucose <140 mg/dL (7.8 mmol/L) 1
- Target random blood glucose <180 mg/dL (10.0 mmol/L) 1
- Reassess insulin regimen if blood glucose falls below 100 mg/dL (5.6 mmol/L) 1
- Modify regimen when blood glucose values are <70 mg/dL (3.9 mmol/L) 1
By following these structured approaches to insulin adjustment, clinicians can effectively manage uncontrolled glucose levels while minimizing the risk of hypoglycemia and optimizing patient outcomes.